Faculty Bibliography

High field strength magnetic resonance imaging (MRI) provides a noninvasive means of evaluating patients with parkinsonism. Using strict clinical criteria, we began a prospective study of patients with Parkinson's disease (PD) and parkinsonian syndromes (PS) including progressive supranuclear palsy (PSP), multiple system atrophy (MSA), and atypical parkinsonism (ATYP). We detected moderate to severe putaminal hypointensity more frequently in PS than in PD and controls, although putaminal hypointensity did not distinguish between MSA, PSP, or ATYP. Signal intensity in the lateral substantia nigra did not differ significantly among patients with PD, PS, or controls and was therefore not a useful MRI marker. Pars compacta width was significantly narrower in both PD and PS. Subcortical and periventricular hyperintense foci were more abundant in PD and PS than controls. Atrophy of the brainstem occurred only in patients with PS

The Tolosa-Hunt syndrome consists of painful ophthalmoplegia caused by cavernous sinus inflammation, which is responsive to steroid therapy. The MR features of 11 patients with the clinical diagnosis of Tolosa-Hunt syndrome were studied. Two patients had normal MR studies of the orbit and cavernous sinuses. In nine patients, abnormal signal and/or mass lesions were seen in the cavernous sinuses; in eight cases, the abnormality was hypointense relative to fat and isointense with muscle on short TR/TE images and isointense with fat on long TR/TE scans. Extension into the orbital apex was seen in eight cases. In six of nine cases the affected cavernous sinus was enlarged; in five of nine it had a convex outer margin. One patient had a thrombosed cavernous sinus and superior ophthalmic vein in addition to a cavernous sinus soft-tissue mass. The signal intensity of Tolosa-Hunt syndrome in this limited series was similar to that of orbital pseudotumor and is confined to a limited differential diagnosis, which includes meningioma, lymphoma, and sarcoidosis

Twenty-nine patients with true arteriovenous malformations as diagnosed by MR imaging or angiography were examined by MR to detect the presence of hemosiderin deposition, a marker for remote hemorrhage. The resulting information was compared with the clinical record to determine the frequency with which MR demonstrated prior hemorrhagic episodes where no clinical evidence for such episodes existed. Twenty (69%) of 29 patients with arteriovenous malformations showed evidence of acute or older hemorrhage. In four (14%) of 29 cases MR showed a hypointense signal on long TR images, suggesting hemosiderin, but no clinical history could account for prior hemorrhage. Additionally, six (21%) of 29 patients had a clinical history suggestive of acute hemorrhage, but no evidence of bleeding was found on MR. The presence of prior or current hemorrhage is critical to deciding whether to surgically resect the arteriovenous malformation or to treat it conservatively, because of the high rate of rebleeding in patients presenting with hemorrhage or those with a history of this disorder. For this reason, MR imaging has an important role in the management of patients with arteriovenous malformations

MR images of 24 patients with 33 subdural collections were retrospectively reviewed to determine the spectrum of MR findings associated with such lesions. The lesions were dated by history, when available. Hematomas were grouped as follows: acute, four; early subacute, four; late subacute, four; chronic, 13. Six collections were classified as rehemorrhage; and two patients had CSF hygromas. Subdural hematomas evolved in a pattern similar to intracerebral hemorrhage with the exception of chronic subdural hematomas, in which isointensity of hypointensity relative to gray matter was observed on short TR/TE images compared with the persistent very high signal intensity noted in chronic parenchymal hematomas. Hemosiderin was rarely seen in chronic hematomas. These findings are most likely the result of the absence of a blood-brain barrier, which allowed clearance and dilution of blood products. Subdural hematomas with repeat hemorrhage demonstrated multiple phases of bleeding with layering phenomenon and more frequent hemosiderin deposition. It is possible that the clearance of blood products, as observed in chronic subdural hematomas, is impaired or poorly functional when rehemorrhage occurs. The persistence of high signal from methemoglobin in a hematoma that is expected to be in the chronic phase also suggests repeated hemorrhage. Acute CSF subdural hygromas had signal intensities identical to CSF without MR evidence of blood products. At surgery, clear fluid under pressure was found. MR imaging, with its unique ability to delineate the various phases of hemorrhage, is well suited to the evaluation of subdural hemorrhage

To investigate the role of MR imaging in wallerian degeneration, a series of animal models of increasingly complex peripheral nerve injury were studied by in vivo MR. Proximal tibial nerves in brown Norway rats were either crushed, transected (neurotomy), or transected and grafted with Lewis rat (allograft) or brown Norway (isograft) donor nerves. The nerves distal to the site of injury were imaged at intervals of 0-54 days after surgery. Subsequent histologic analysis was obtained and correlated with MR findings. Crush injury, neurotomy, and nerve grafting all resulted in high signal intensity along the course of the nerve observed on long TR/TE sequences, corresponding to edema and myelin breakdown from wallerian degeneration. The abnormal signal intensity resolved by 30 days after crush injury and by 45-54 days after neurotomy, when the active changes of wallerian degeneration had subsided. These changes were not seen in sham-operated rats. Our findings suggest that MR is capable of identifying traumatic neuropathy in a peripheral nerve undergoing active wallerian degeneration. The severity of injury may be reflected by the corresponding duration of signal abnormality. With the present methods, MR did not distinguish inflammatory from simple posttraumatic neuropathy

The appearance on magnetic resonance (MR) images of the normal pars interarticularis in 13 patients was reviewed and contrasted with that of the pars in eight patients with spondylolysis. The pars defect usually had an intermediate signal intensity with all pulse sequences; however, this intensity was somewhat variable depending on the exact ratio of cartilage, fat, and fluid within each bone defect. The pars defect was best seen with spin-echo 600/20 (repetition time msec/echo time msec) images. In three cases, out-of-phase images showed the spondylolysis best, because of extension of fat to the borders of the defect. The sagittal view allowed one to separate spondylolysis from the joint space of posterior facets since the orientation of the defects is perpendicular to the facets; thus, a common pitfall encountered with cross-sectional axial imaging techniques is avoided. MR imaging poorly delineated bone fragments around the defect, which may produce nerve root impingement, but revealed other numerous complications that occur with spondylolysis, including spondylolisthesis and herniation of the disk above

High-field MR with both spin-echo and gradient-echo sequences was performed in 21 patients with (idiopathic, drug-responsive) Parkinson disease. The use of gradient echoes allowed more sensitive detection than did spin echoes of susceptibility changes in the putamina and substantia nigra. No statistically significant difference in putaminal hypointensity on long TR/long TE spin-echo sequences or on T2*-weighted images using gradient-echo sequences was observed between Parkinson patients and controls. There was also no statistically significant difference in the frequency of restoration of the signal intensity of the substantia nigra between the two groups of patients. The width of the pars compacta of the substantia nigra in patients with Parkinson disease was 2.12 + 0.82 mm (mean +/- SD). This value in age- and gender-matched controls was 2.67 +/- 0.5. Comparing these two groups with an unpaired t test resulted in a p value less than or equal to .005. Our MR study with spin-echo and gradient-echo images in Parkinson and control patients was able to substantiate and elaborate on previously described MR features of Parkinson disease